We have no patient photos, and we are not going to invent any.
GHK-Cu before and after searches almost always land on photo galleries, and almost none of those images come from controlled research. HELiXVi holds no patient photographs and no patient testimonials for GHK-Cu, so this page presents something different: what published studies actually measured, over what timeframe, and where the evidence stops. If you want the peptide background first, read our GHK-Cu peptide guide, and to see how copper peptides fit a broader plan, visit longevity and peptide therapy. GHK-Cu is not FDA-approved, human research is limited, and individual results vary.
Instead of photographs, the useful GHK-Cu literature reports instrument and tissue measures. In skin research, small controlled studies of copper peptide creams have reported changes in measures such as skin density and thickness assessed by ultrasound, elasticity and firmness measures, and visual scoring of fine lines by blinded assessors over roughly twelve weeks of daily topical use. In wound healing research, endpoints have included closure rate and time to closure in animal models and small human studies. In laboratory work, researchers have measured collagen and glycosaminoglycan synthesis in fibroblast cultures and changes in gene expression associated with tissue maintenance. Those are real findings, and they are also modest, short, small, and often preclinical. No large, long-term, independently replicated human trial establishes cosmetic outcomes for GHK-Cu, and nothing here should be read as a claim to treat any condition.
You can find a hundred pages promising a transformation and showing photographs nobody can verify. We would rather tell you what the research measured, admit how limited it is, and let you decide. If that approach suits you, look at how we handle the rest of it on longevity and peptide therapy, and read our GHK-Cu side effects page for the other half of the picture.
Because we have none, and we will not invent them. We hold no patient photographs or testimonials for GHK-Cu. Publishing unverifiable images would misrepresent what the evidence supports.
Most topical skin studies ran for around twelve weeks and measured modest instrument-recorded changes. Individual results vary and there is no guarantee of any visible outcome.
Some may be genuine, but almost none come from controlled studies, and lighting, angle, timing, and selection bias make them unreliable either way. Treat them as marketing.
Skin density and thickness, elasticity, blinded visual scoring of fine lines, and in wound research, closure endpoints. Laboratory studies measured collagen synthesis and gene expression in cell cultures.
There is no reliable human evidence supporting that claim. Injectable use has less published human data than topical use, as explained on our GHK-Cu peptide injection page.
No evidence supports that, and higher concentrations can increase irritation. How strength and frequency are chosen is covered on our GHK-Cu dosage page.
GHK-Cu is not FDA-approved. HELiXVi publishes no patient photographs, testimonials, or outcome data for GHK-Cu, and makes no guarantee of results. Compounded GHK-Cu preparations are prepared by US state-licensed pharmacies and are not FDA-approved. Prescription products require an online consultation with a licensed US clinician where clinically appropriate; approval is not guaranteed. Human research on GHK-Cu is limited and much of it is preclinical or small-scale. Statements on this page have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results vary.
Start your free consultation right now
No clinic visit. Licensed US clinicians. Dispatched within 24 hours of your consultation and payment.